Our full line of Digital Pathology Services is built on industry-leading digital pathology solution platforms that are fully validated for Clinical Trial Studies. We perform Whole Slide Imaging, Multiplex IF/IHC, and Image Analysis services under CLIA and GLP compliance.
iCura Diagnostics takes pride in offering a comprehensive range of Digital Pathology Services that are designed to transform the landscape of clinical trial studies. Our industry-leading digital pathology solution platforms, fully validated for Clinical Trial Studies, enable us to provide cutting-edge services such as Whole Slide Imaging, Multiplex IF/IHC, and Image Analysis. With a steadfast commitment to compliance, we ensure that all our services are performed under CLIA and GLP standards, guaranteeing accurate and reliable results for our clients.
At iCura, we aim to fulfill the critical role that digital pathology plays in advancing clinical trial studies. Our full line of Digital Pathology Services is built on industry-leading platforms that have undergone rigorous validation processes specifically tailored for Clinical Trial Studies. This ensures that our services meet the highest standards of quality, accuracy, and compliance.
One of the key services we offer is Whole Slide Imaging. By digitizing glass slides, we enable seamless access, sharing, and analysis of pathology images. Our state-of-the-art scanning technology captures high-resolution images with exceptional clarity, allowing for detailed examination and analysis of tissue samples. With Whole Slide Imaging, researchers and pathologists can easily navigate through slides, annotate regions of interest, and collaborate remotely, leading to more efficient and collaborative clinical trial studies.
In addition to Whole Slide Imaging, we specialize in Multiplex IF/IHC services, which leverage the power of immunofluorescence and immunohistochemistry to simultaneously detect and visualize multiple biomarkers within a single tissue section. This advanced technique provides comprehensive insights into protein expression patterns, cellular interactions, and spatial relationships, allowing for a deeper understanding of disease mechanisms and treatment responses. Our validated Multiplex IF/IHC services enable researchers to uncover valuable biomarker data and generate more robust findings for their clinical trial studies.
Image Analysis is another integral component of our Digital Pathology Services. Leveraging cutting-edge algorithms and software, we analyze digital pathology images to extract quantitative and qualitative data. Our team of experienced pathologists and image analysis experts utilize advanced techniques to measure biomarker expression levels, assess tissue morphological characteristics, and quantify various pathological features. This objective and automated approach enhances the accuracy, consistency, and efficiency of data analysis, providing valuable insights for clinical trial studies.
We understand the critical importance of compliance in clinical trial studies. That’s why we perform all our Digital Pathology Services under CLIA (Clinical Laboratory Improvement Amendments) and GLP (Good Laboratory Practice) regulations. These stringent quality control standards ensure that our laboratory operations, processes, and data management adhere to the highest levels of accuracy, precision, and reliability. By upholding CLIA and GLP compliance, we provide our clients with the confidence that our services meet the necessary regulatory requirements, maintaining the integrity and validity of their clinical trial studies.
iCura’s Digital Pathology Services offer a comprehensive range of solutions for clinical trial studies. Our validated platforms, including Whole Slide Imaging, Multiplex IF/IHC, and Image Analysis, empower researchers and pathologists to gain deeper insights into diseases, biomarkers, and treatment responses. With a steadfast commitment to CLIA and GLP compliance, we ensure the highest quality standards, accuracy, and regulatory compliance in all our services. Partner with iCura and revolutionize your clinical trial studies with our industry-leading Digital Pathology Services.
